Royal Bank Of Canada Organogenesis Holdings Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 59,568 shares of ORGO stock, worth $201,339. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,568
Previous 74,778
20.34%
Holding current value
$201,339
Previous $213,000
10.8%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ORGO
# of Institutions
124Shares Held
62MCall Options Held
4.3KPut Options Held
3.9K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$42.2 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$40 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$12.1 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$10.4 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $442M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...